Marcelin Jasmine R, Swartz Talia H, Bernice Fidelia, Berthaud Vladimir, Christian Robbie, da Costa Christopher, Fadul Nada, Floris-Moore Michelle, Hlatshwayo Matifadza, Johansson Patrik, Kullar Ravina, Manning Kimberly, McGee Edoabasi U, Medlin Christopher, Piggott Damani A, Syed Uzma, Snowden Jessica, Tan Tina, Abdul-Mutakabbir Jacinda C
Division of Infectious Diseases, University of Nebraska Medical Center, Omaha Nebraska, USA.
Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Open Forum Infect Dis. 2021 Aug 9;8(9):ofab417. doi: 10.1093/ofid/ofab417. eCollection 2021 Sep.
During the coronavirus disease 2019 (COVID-19) pandemic, we have witnessed profound health inequities suffered by Black, Indigenous, and People of Color (BIPOC). These manifested as differential access to testing early in the pandemic, rates of severe disease and death 2-3 times higher than white Americans, and, now, significantly lower vaccine uptake compared with their share of the population affected by COVID-19. This article explores the impact of these COVID-19 inequities (and the underlying cause, structural racism) on vaccine acceptance in BIPOC populations, ways to establish trustworthiness of healthcare institutions, increase vaccine access for BIPOC communities, and inspire confidence in COVID-19 vaccines.
在2019年冠状病毒病（COVID-19）大流行期间，我们目睹了黑人、原住民和有色人种（BIPOC）所遭受的严重健康不平等。这些不平等表现为在疫情初期获得检测的机会不同、严重疾病和死亡率比美国白人高2至3倍，以及现在与受COVID-19影响的人口比例相比，疫苗接种率显著较低。本文探讨了这些COVID-19不平等现象（以及潜在原因，即结构性种族主义）对BIPOC人群疫苗接受度的影响、建立医疗机构可信度的方法、增加BIPOC社区获得疫苗的机会，以及激发对COVID-19疫苗的信心。
